These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8766263)

  • 1. [Metabolic syndrome and fatal quartet].
    Standl E
    Internist (Berl); 1996 Jul; 37(7):698-704. PubMed ID: 8766263
    [No Abstract]   [Full Text] [Related]  

  • 2. [The metabolic syndrome and chronic vascular disease. Cellular mechanisms and potential candidate genes].
    Haller H; Knoblauch H; Schuster H; Luft FC
    Internist (Berl); 1996 Jul; 37(7):687-97. PubMed ID: 8766262
    [No Abstract]   [Full Text] [Related]  

  • 3. The insulin resistance syndrome.
    Smolar EN
    Compr Ther; 1997 Apr; 23(4):237-43. PubMed ID: 9167914
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin resistance: the clinical spectrum.
    Mantzoros CS; Flier JS
    Adv Endocrinol Metab; 1995; 6():193-232. PubMed ID: 7671097
    [No Abstract]   [Full Text] [Related]  

  • 5. [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].
    Pedersen O
    Ugeskr Laeger; 1992 May; 154(20):1411-8. PubMed ID: 1631967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The deadly quartet--the insulin resistance syndrome.
    Opara JU; Levine JH
    South Med J; 1997 Dec; 90(12):1162-8. PubMed ID: 9404899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome.
    Lee SC; Pu YB; Thomas GN; Lee ZS; Tomlinson B; Cockram CS; Critchley JA; Chan JC
    Metabolism; 2000 Aug; 49(8):1021-4. PubMed ID: 10954020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Integrated drug therapy of the metabolic syndrome].
    Julius U; Hanefeld M
    Internist (Berl); 1996 Jul; 37(7):722-30. PubMed ID: 8766266
    [No Abstract]   [Full Text] [Related]  

  • 9. [The misconstrued metabolic syndrome essential hypertension. Chronology of interdisciplinary change in attitude].
    Rett K; Wicklmayr M; Dietze G; Mehnert H
    Med Klin (Munich); 1991 Feb; 86(2):86-91. PubMed ID: 2030665
    [No Abstract]   [Full Text] [Related]  

  • 10. Chromium deficiency might contribute to insulin resistance, type 2 diabetes mellitus, dyslipidaemia, and atherosclerosis.
    Mahdi GS
    Diabet Med; 1996 Apr; 13(4):389-90. PubMed ID: 9162617
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical implications of insulin resistance.
    Peters AL
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Insulin resistance--possible causes and effects].
    Bornkessel B
    Med Monatsschr Pharm; 1996 Mar; 19(3):81-4. PubMed ID: 8868967
    [No Abstract]   [Full Text] [Related]  

  • 13. [Syndrome X and general medicine].
    Guillaume G; Moinie S; Bauler A
    Rev Med Brux; 1995; 16(2):79-82. PubMed ID: 7784742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic aspects of diabetes and its cardiovascular complications: contribution of genetics to risk assessment and clinical management.
    St-Pierre J; Vohl MC; Després JP; Gaudet D; Poirier P
    Can J Cardiol; 2005 Feb; 21(2):199-209. PubMed ID: 15729423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of the metabolic syndrome].
    Hanefeld M; Willms B
    Internist (Berl); 1996 Jul; 37(7):705-11. PubMed ID: 8766264
    [No Abstract]   [Full Text] [Related]  

  • 16. Exercise and the metabolic syndrome.
    Eriksson J; Taimela S; Koivisto VA
    Diabetologia; 1997 Feb; 40(2):125-35. PubMed ID: 9049471
    [No Abstract]   [Full Text] [Related]  

  • 17. [Genetic predisposition for multiple metabolic syndrome. Part 1. Diabetes mellitus type 2--incidence and prevalence].
    Sobra J
    Cas Lek Cesk; 1999 Jan; 138(1):6-11. PubMed ID: 10953428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone and the metabolic syndrome.
    Johannsson G; Bengtsson BA
    J Endocrinol Invest; 1999; 22(5 Suppl):41-6. PubMed ID: 10442570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome as a cardiovascular risk factor.
    Krone W; Meinertz T
    Herz; 1995 Feb; 20(1):2-4. PubMed ID: 7713474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.